U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Uveal Melanoma

MedGen UID:
75885
•Concept ID:
C0278870
•
Neoplastic Process
Synonyms: Recurrent Melanoma of the Uvea; Recurrent Melanoma of Uvea

Definition

The reemergence of uveal melanoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Uveal Melanoma

Professional guidelines

PubMed

Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
Marucci L, Lane AM, Li W, Egan KM, Gragoudas ES, Adams JA, Collier JM, Munzenrider JE
Int J Radiat Oncol Biol Phys 2006 Mar 15;64(4):1018-22. Epub 2006 Jan 10 doi: 10.1016/j.ijrobp.2005.09.035. PMID: 16376492
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, Papadopoulos N, Benjamin RS
Cancer 1995 Nov 1;76(9):1665-70. doi: 10.1002/1097-0142(19951101)76:9<1665::aid-cncr2820760925>3.0.co;2-j. PMID: 8635073

Recent clinical studies

Etiology

Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma.
Kim JH, Shin SJ, Heo SJ, Choe EA, Kim CG, Jung M, Keum KC, Yoon JS, Lee SC, Shin SJ
Cancer Res Treat 2018 Oct;50(4):1238-1251. Epub 2017 Dec 28 doi: 10.4143/crt.2017.534. PMID: 29281872Free PMC Article
Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation.
Verma V, Rwigema JM, Malyapa RS, Regine WF, Simone CB 2nd
Radiother Oncol 2017 Oct;125(1):21-30. Epub 2017 Sep 20 doi: 10.1016/j.radonc.2017.08.005. PMID: 28941560
Salvage proton beam therapy in local recurrent uveal melanoma.
Riechardt AI, Cordini D, Dobner B, Seibel I, Gundlach E, Rehak M, Hager A, Stark R, Moser L, Joussen AM
Am J Ophthalmol 2014 Nov;158(5):948-56. Epub 2014 Jul 16 doi: 10.1016/j.ajo.2014.07.013. PMID: 25038327
Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation.
Marucci L, Ancukiewicz M, Lane AM, Collier JM, Gragoudas ES, Munzenrider JE
Int J Radiat Oncol Biol Phys 2011 Mar 1;79(3):842-6. Epub 2010 May 14 doi: 10.1016/j.ijrobp.2009.12.018. PMID: 20472356
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, Papadopoulos N, Benjamin RS
Cancer 1995 Nov 1;76(9):1665-70. doi: 10.1002/1097-0142(19951101)76:9<1665::aid-cncr2820760925>3.0.co;2-j. PMID: 8635073

Diagnosis

Multicentric recurrent uveal melanoma.
Menon V, Thulasidas M, Narula R, Mulay K, Honavar SG
Indian J Ophthalmol 2020 Oct;68(10):2305-2307. doi: 10.4103/ijo.IJO_511_20. PMID: 32971703Free PMC Article
Scleral Necrosis Simulating Recurrent Uveal Melanoma after Plaque Brachytherapy.
Burris CKH, Rodriguez ME, Potter HD
Ophthalmology 2016 Aug;123(8):1761. doi: 10.1016/j.ophtha.2016.04.054. PMID: 27450820
Salvage proton beam therapy in local recurrent uveal melanoma.
Riechardt AI, Cordini D, Dobner B, Seibel I, Gundlach E, Rehak M, Hager A, Stark R, Moser L, Joussen AM
Am J Ophthalmol 2014 Nov;158(5):948-56. Epub 2014 Jul 16 doi: 10.1016/j.ajo.2014.07.013. PMID: 25038327
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, Papadopoulos N, Benjamin RS
Cancer 1995 Nov 1;76(9):1665-70. doi: 10.1002/1097-0142(19951101)76:9<1665::aid-cncr2820760925>3.0.co;2-j. PMID: 8635073

Therapy

Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation.
Verma V, Rwigema JM, Malyapa RS, Regine WF, Simone CB 2nd
Radiother Oncol 2017 Oct;125(1):21-30. Epub 2017 Sep 20 doi: 10.1016/j.radonc.2017.08.005. PMID: 28941560
Scleral Necrosis Simulating Recurrent Uveal Melanoma after Plaque Brachytherapy.
Burris CKH, Rodriguez ME, Potter HD
Ophthalmology 2016 Aug;123(8):1761. doi: 10.1016/j.ophtha.2016.04.054. PMID: 27450820
Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection.
Damato BE, Paul J, Foulds WS
Br J Ophthalmol 1996 Feb;80(2):102-8. doi: 10.1136/bjo.80.2.102. PMID: 8814738Free PMC Article
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, Papadopoulos N, Benjamin RS
Cancer 1995 Nov 1;76(9):1665-70. doi: 10.1002/1097-0142(19951101)76:9<1665::aid-cncr2820760925>3.0.co;2-j. PMID: 8635073

Prognosis

Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma.
Kim JH, Shin SJ, Heo SJ, Choe EA, Kim CG, Jung M, Keum KC, Yoon JS, Lee SC, Shin SJ
Cancer Res Treat 2018 Oct;50(4):1238-1251. Epub 2017 Dec 28 doi: 10.4143/crt.2017.534. PMID: 29281872Free PMC Article
Salvage proton beam therapy in local recurrent uveal melanoma.
Riechardt AI, Cordini D, Dobner B, Seibel I, Gundlach E, Rehak M, Hager A, Stark R, Moser L, Joussen AM
Am J Ophthalmol 2014 Nov;158(5):948-56. Epub 2014 Jul 16 doi: 10.1016/j.ajo.2014.07.013. PMID: 25038327
Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation.
Marucci L, Ancukiewicz M, Lane AM, Collier JM, Gragoudas ES, Munzenrider JE
Int J Radiat Oncol Biol Phys 2011 Mar 1;79(3):842-6. Epub 2010 May 14 doi: 10.1016/j.ijrobp.2009.12.018. PMID: 20472356
Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection.
Damato BE, Paul J, Foulds WS
Br J Ophthalmol 1996 Feb;80(2):102-8. doi: 10.1136/bjo.80.2.102. PMID: 8814738Free PMC Article
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, Papadopoulos N, Benjamin RS
Cancer 1995 Nov 1;76(9):1665-70. doi: 10.1002/1097-0142(19951101)76:9<1665::aid-cncr2820760925>3.0.co;2-j. PMID: 8635073

Clinical prediction guides

Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection.
Damato BE, Paul J, Foulds WS
Br J Ophthalmol 1996 Feb;80(2):102-8. doi: 10.1136/bjo.80.2.102. PMID: 8814738Free PMC Article
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, Papadopoulos N, Benjamin RS
Cancer 1995 Nov 1;76(9):1665-70. doi: 10.1002/1097-0142(19951101)76:9<1665::aid-cncr2820760925>3.0.co;2-j. PMID: 8635073

Recent systematic reviews

Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation.
Verma V, Rwigema JM, Malyapa RS, Regine WF, Simone CB 2nd
Radiother Oncol 2017 Oct;125(1):21-30. Epub 2017 Sep 20 doi: 10.1016/j.radonc.2017.08.005. PMID: 28941560

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...